More than 200,000 Australians could benefit from breakthroughs on a debilitating neurological disorder under a new national ...

Some 10,929 Australians with Parkinson’s were surveyed and provided saliva samples for genetic analysis. This is the largest ...

A recent study in Australia provides new insights into Parkinson's disease, emphasizing the prevalence of non-motor symptoms, the role of genetics and environment, and gender differences in its ...

Parkinson's disease is the fastest-growing neurological disorder, with over 10 million cases worldwide. Up to 150,000 ...

Gain Therapeutics announces Phase 1b clinical trial approval in Australia for GT-02287 to evaluate safety in Parkinson's disease patients. Gain Therapeutics, Inc. has received approval to start ...

Largest ever Parkinson's study shows how symptoms differ between men, women ...

Researchers based at Australia’s Translational Research Institute (TRI) have received major funding from the United States Department of Defense (DoD) to develop Parkinson’s disease (PD) treatments by ...